The University of Southampton
University of Southampton Institutional Repository

Investigating neurodegeneration in a Drosophila model of tauopathy

Investigating neurodegeneration in a Drosophila model of tauopathy
Investigating neurodegeneration in a Drosophila model of tauopathy
Axonal degeneration occurring in disease is thought to be similar to that occurring after acute injury, known as Wallerian degeneration. Wallerian degeneration is an active process that can be delayed by the expression of the slow Wallerian degeneration (WldS) protein. In this project I sought to investigate whether WldS could delay axonal degeneration in a model of neurodegenerative disease: tauopathy. Tauopathy is characterised by neuronal dysfunction and degeneration occurring as a result of changes to the microtubule associated protein tau.
Using Drosophila co-expressing htau0N3R and WldS, neuronal dysfunction was investigated in larvae. However, WldS did not improve tau-mediated deficits in axonal transport, synaptic alterations and locomotor behaviour, indicating WldS does not improve tau-mediated neuronal dysfunction. Furthermore, co-expression in the adult system, in which both neuronal dysfunction and degeneration occur, did not improve locomotor behaviour nor delay the onset or slow the progression of axonal swellings indicative of axonal degeneration. A significant increase in lifespan was observed, however as this was not accompanied by delayed axonal degeneration this is likely to be an off target effect. The failure of WldS to delay tau-mediated axonal degeneration suggests that a different mechanism controls axonal degeneration in disease than in injury. Supporting this, following axotomy htau0N3R;WldS axons displayed robust protection on a par with WldS axons. Interestingly, subsequent bystander protection against tau-mediated axonal swellings was observed in injured htau0N3R;WldS axons. This further supports that different mechanisms control axonal degeneration in chronic disease and acute injury.

Mitochondria play an important role in neuronal dysfunction and degeneration in tauopathy, but how this contributes to axonal degeneration remains unclear. Expression of htau0N3R results in mitochondrial mislocalisation in the larval model of neuronal dysfunction. Restabilising the microtubule cytoskeleton using the drug NAP restored axonal transport but did not rescue mitochondrial mislocalisation, indicating that the mislocalisation is not simply due to the loss microtubule stabilisation by tau.
Stubbs, Katy
5e5b95de-e497-432d-8bc9-d3bc95919fb6
Stubbs, Katy
5e5b95de-e497-432d-8bc9-d3bc95919fb6
Mudher, Amritpal
ce0ccb35-ac49-4b6c-92b4-8dd5e78ac119

(2015) Investigating neurodegeneration in a Drosophila model of tauopathy. University of Southampton, Faculty of Natural and Environmental Sciences, Doctoral Thesis, 186pp.

Record type: Thesis (Doctoral)

Abstract

Axonal degeneration occurring in disease is thought to be similar to that occurring after acute injury, known as Wallerian degeneration. Wallerian degeneration is an active process that can be delayed by the expression of the slow Wallerian degeneration (WldS) protein. In this project I sought to investigate whether WldS could delay axonal degeneration in a model of neurodegenerative disease: tauopathy. Tauopathy is characterised by neuronal dysfunction and degeneration occurring as a result of changes to the microtubule associated protein tau.
Using Drosophila co-expressing htau0N3R and WldS, neuronal dysfunction was investigated in larvae. However, WldS did not improve tau-mediated deficits in axonal transport, synaptic alterations and locomotor behaviour, indicating WldS does not improve tau-mediated neuronal dysfunction. Furthermore, co-expression in the adult system, in which both neuronal dysfunction and degeneration occur, did not improve locomotor behaviour nor delay the onset or slow the progression of axonal swellings indicative of axonal degeneration. A significant increase in lifespan was observed, however as this was not accompanied by delayed axonal degeneration this is likely to be an off target effect. The failure of WldS to delay tau-mediated axonal degeneration suggests that a different mechanism controls axonal degeneration in disease than in injury. Supporting this, following axotomy htau0N3R;WldS axons displayed robust protection on a par with WldS axons. Interestingly, subsequent bystander protection against tau-mediated axonal swellings was observed in injured htau0N3R;WldS axons. This further supports that different mechanisms control axonal degeneration in chronic disease and acute injury.

Mitochondria play an important role in neuronal dysfunction and degeneration in tauopathy, but how this contributes to axonal degeneration remains unclear. Expression of htau0N3R results in mitochondrial mislocalisation in the larval model of neuronal dysfunction. Restabilising the microtubule cytoskeleton using the drug NAP restored axonal transport but did not rescue mitochondrial mislocalisation, indicating that the mislocalisation is not simply due to the loss microtubule stabilisation by tau.

PDF
Katy Stubbs.Thesis Corrected Final 23Mar2016.pdf - Other
Download (9MB)

More information

Published date: June 2015
Organisations: University of Southampton, Centre for Biological Sciences

Identifiers

Local EPrints ID: 395374
URI: http://eprints.soton.ac.uk/id/eprint/395374
PURE UUID: ce34149d-1d86-485c-a8ff-53bb0d1cc20c

Catalogue record

Date deposited: 06 Jul 2016 13:22
Last modified: 17 Jul 2017 18:54

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×